3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia
7
Leukemia, Myeloid, Acute
5
Neoplasms
3
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Depression
2
Prostatic Neoplasms
1
Osteonecrosis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mastocytosis, Systemic
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid
1
Leukemia, Mast-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypertension
1
Genetic Predisposition to Disease
1
Colorectal Neoplasms
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Brain Neoplasms
1
Anxiety Disorders
1
Interventions
Cytarabine
14
fludarabine
13
venetoclax
11
Imatinib Mesylate
9
Cyclophosphamide
8
Azacitidine
8
fludarabine phosphate
7
Busulfan
7
Whole-Body Irradiation
6
Tacrolimus
6
Mycophenolic Acid
6
thymoglobulin
4
ponatinib
4
nilotinib
4
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
asciminib
3
aldesleukin
3
Melphalan
3
Interleukin-2
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Decitabine
3
Bone Marrow Transplantation
3
Antilymphocyte Serum
3
zosuquidar trihydrochloride
2
gilteritinib
2
enasidenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
Interviews as Topic
×
Other hematologic neoplasm
×
Clear all
NCT05309018
2024-05-23
LAMIPA
Centre Hospitalier Régional Metz-Thionville
Withdrawn